A novel way to isolate MSCs from umbilical cords
A novel way to isolate MSCs from umbilical cords
复制标题
从脐带中分离间充质干细胞的新方法
DOI:
10.1002/eji.201142356
复制
发表时间:
2012-08-01
影响因子:
5.4
通讯作者:
Hou, Yayi
中科院分区:
文献类型:
--
作者:
Liu, Liu;Zhao, Xiaoyin;Hou, Yayi
Mesenchymal stem cells (MSCs) not only possess extensive self-renewal potential and can modulate immune cell activation [1], but also they are easily expanded and stored ex vivo, and are considered to be “immune privileged.” MSCs modulate the function of immune cells, including T and B lymphocytes, dendritic cells, and natural killer cells, inhibit their proliferation and alter their cytokine secretion. Previous data from our group and others [2–4] demonstrated the immunosuppressive and antiinflammatory effects of MSCs in the treatment of several animal disease models including autoimmune diseases. As a result of these unique qualities, MSCs are attractive candidates in stem cell-based therapy. The first successful isolation of fibroblast-like colonies from bone marrow, that is, MSCs, was described four decades ago by Friedenstein et al.[5]. The isolation method was based on the adherence of bone marrow-derived, fibroblast-like cells to the plastic cell culture plate, and a concomitant lack of adherence of bone marrow-derived hematopoietic cells. MSCs separated by adherence have uniform cell morphology and long-term culture expansion, and the cost of this method is low that makes it desirable as a practical method of production. However, it is reported that MSC separation using the traditional cell-adherent method will not yield good results because MSCs are rare in tissue; the proportion of MSCs in the bone marrow is less than 1: 10,000 mononuclear cells [6, 7]. Therefore, it is difficult to obtain enough MSCs from bone marrow for medical use. In addition, the maternal–fetal interface is an important source of MSCs, and several groups have isolated MSCs from umbilical cord, placenta, and decidua [8–10]. Umbilical cord tissue, which is considered as a clinical waste, is the most stable and readily available source of MSCs and of worth studying.Florian et al.[11] reported that cell isolation protocols have a major impact on the functional activity of bone marrowderived progenitor cells, highlighting the importance of optimizing MSC isolation protocols. There are four methods reported to separate MSCs:(i) flow cytometrical sorting [12];(ii) magnetic separation [13];(iii) density gradient centrifugation [14]; and (iv) the cell plastic adherence method [15, 16]. Since there are no specific surface markers for MSCs, it is difficult to separate MSCs from the digested cell pellet [17]. Although several reports describe the use of CD133, CD271, and CD105 as markers to separate MSCs [18–20], this method also requires several negative markers (CD3, CD14, CD19, CD38, and CD66b) to assist sorting. In addition, flow cytometrical sorting and magnetic separation have large effects on cell viability and require sophisticated equipment. Therefore, these methods are not yet widely used. Density gradient centrifugation, on the other hand, also requires sophisticated equipment and a suitable separation medium and is therefore not suitable for large-scale production of MSCs.